494 reports of this reaction
2.6% of all ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR reports
#8 most reported adverse reaction
WEIGHT INCREASED is the #8 most commonly reported adverse reaction for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, manufactured by Vertex Pharmaceuticals Incorporated. There are 494 FDA adverse event reports linking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR to WEIGHT INCREASED. This represents approximately 2.6% of all 19,269 adverse event reports for this drug.
Patients taking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR who experience weight increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT INCREASED is a less commonly reported adverse event for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, but still significant enough to appear in the safety profile.
In addition to weight increased, the following adverse reactions have been reported for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR:
The following drugs have also been linked to weight increased in FDA adverse event reports:
WEIGHT INCREASED has been reported as an adverse event in 494 FDA reports for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT INCREASED accounts for approximately 2.6% of all adverse event reports for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, making it a notable side effect.
If you experience weight increased while taking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.